Internet of Things - IOT

This Frost & Sullivan market insight identifies the key competitive attributes for machine-to-machine (M2M) and Internet of Things (IoT) virtual network operators (VNOs) in North America. It also highlights the strengths, opportunities, and challenges for the leading M2M VNOs.

This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...

Open Source Innovation in the context of pharma and biotech is an issue based deliverable that gives an overview of this space and analyses the key drivers and barriers of this area. It gives an overview of the key problems faced by the pharmaceutical industry today, past, present and future strategies to tackle these problems, new strategies to im...

This market insight on contract sales and marketing organisations throws light on the changing dynamics and the opportunities that lie ahead for these organisations in the future.

This issue of Vital Signs, released on May 18, 2009, provides a strategic overview of opportunities and issues in the pharmaceutical and biotechnology outsourcing services markets. Additionally, a company spotlight is provided for Aerie Pharmaceuticals, an emerging pharma company focused on glaucoma. Reimbursement and regulatory news from the FDA i...

This research service provides insights into M&A activities, trends and strategic analysis in the pharma- biotech space.

This research service aims to profile some of the promising biotech companies in Europe across different countries and segments.